Aripiprazole Augmentation Versus Switching to Different Class of Antidepressants in Major Depressive Disorder
Status:
Unknown status
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to compare the efficacy and safety of aripiprazole as
adjunctive therapy versus switching to different class of antidepressants for treating major
depressive disorder partially or minimally responsive to ongoing antidepressant treatment.